<code id='71B101F339'></code><style id='71B101F339'></style>
    • <acronym id='71B101F339'></acronym>
      <center id='71B101F339'><center id='71B101F339'><tfoot id='71B101F339'></tfoot></center><abbr id='71B101F339'><dir id='71B101F339'><tfoot id='71B101F339'></tfoot><noframes id='71B101F339'>

    • <optgroup id='71B101F339'><strike id='71B101F339'><sup id='71B101F339'></sup></strike><code id='71B101F339'></code></optgroup>
        1. <b id='71B101F339'><label id='71B101F339'><select id='71B101F339'><dt id='71B101F339'><span id='71B101F339'></span></dt></select></label></b><u id='71B101F339'></u>
          <i id='71B101F339'><strike id='71B101F339'><tt id='71B101F339'><pre id='71B101F339'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:856
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Top private equity targets in 2023: cardiology, clinical trials, lasers
          Top private equity targets in 2023: cardiology, clinical trials, lasers

          AdobeBysomemeasures,privateequityinvestmentlaggedin2023,ayearmarkedbygrowingdistressandhigh-profiled

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Top private equity targets in 2023: cardiology, clinical trials, lasers

          AdobeBysomemeasures,privateequityinvestmentlaggedin2023,ayearmarkedbygrowingdistressandhigh-profiled